ICPT Annual Net Income
$221.82 M
+$313.24 M+342.62%
31 December 2022
Summary:
As of February 5, 2025, ICPT annual net profit is $221.82 million, with the most recent change of +$313.24 million (+342.62%) on December 31, 2022. During the last 3 years, it has risen by +$566.50 million (+164.35%).ICPT Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ICPT Quarterly Net Income
-$2.79 M
+$3.07 M+52.41%
30 September 2023
Summary:
As of February 5, 2025, ICPT quarterly net profit is -$2.79 million, with the most recent change of +$3.07 million (+52.41%) on September 30, 2023. Over the past year, it has dropped by -$270.24 million (-101.04%).ICPT Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ICPT TTM Net Income
-$61.61 M
-$270.24 M-129.53%
30 September 2023
Summary:
As of February 5, 2025, ICPT TTM net profit is -$61.61 million, with the most recent change of -$270.24 million (-129.53%) on September 30, 2023. Over the past year, it has dropped by -$267.97 million (-129.86%).ICPT TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ICPT Net Income Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +342.6% | -101.0% | -129.9% |
3 y3 years | +164.3% | +95.8% | +80.8% |
5 y5 years | +161.6% | +95.7% | +82.1% |
ICPT Net Income High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | ||||||
5 y | 5-year | ||||||
alltime | all time | at high | -101.0% | -127.8% |
Intercept Pharmaceuticals Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2023 | - | -$2.79 M(-52.4%) | -$61.61 M(-129.5%) |
June 2023 | - | -$5.86 M(-81.8%) | $208.63 M(+0.8%) |
Mar 2023 | - | -$32.13 M(+54.3%) | $206.97 M(-6.7%) |
Dec 2022 | $221.82 M(-342.6%) | -$20.82 M(-107.8%) | $221.82 M(+7.5%) |
Sept 2022 | - | $267.45 M(-3652.8%) | $206.36 M(-418.8%) |
June 2022 | - | -$7.53 M(-56.4%) | -$64.72 M(-5.2%) |
Mar 2022 | - | -$17.28 M(-52.4%) | -$68.29 M(-25.3%) |
Dec 2021 | -$91.43 M(-66.7%) | -$36.28 M(+898.9%) | -$91.43 M(-14.8%) |
Sept 2021 | - | -$3.63 M(-67.3%) | -$107.29 M(-36.9%) |
June 2021 | - | -$11.09 M(-72.6%) | -$170.13 M(-23.5%) |
Mar 2021 | - | -$40.42 M(-22.5%) | -$222.32 M(-19.1%) |
Dec 2020 | -$274.88 M(-20.3%) | -$52.15 M(-21.5%) | -$274.88 M(-14.3%) |
Sept 2020 | - | -$66.47 M(+5.0%) | -$320.89 M(-5.4%) |
June 2020 | - | -$63.28 M(-31.9%) | -$339.25 M(-2.3%) |
Mar 2020 | - | -$92.98 M(-5.3%) | -$347.39 M(+0.8%) |
Dec 2019 | -$344.68 M(+11.5%) | -$98.16 M(+15.7%) | -$344.68 M(+3.0%) |
Sept 2019 | - | -$84.83 M(+18.8%) | -$334.53 M(+6.5%) |
June 2019 | - | -$71.42 M(-20.9%) | -$314.15 M(-1.2%) |
Mar 2019 | - | -$90.27 M(+2.6%) | -$317.92 M(+2.8%) |
Dec 2018 | -$309.24 M(-14.2%) | -$88.00 M(+36.5%) | -$309.24 M(-7.0%) |
Sept 2018 | - | -$64.45 M(-14.3%) | -$332.51 M(-2.4%) |
June 2018 | - | -$75.19 M(-7.8%) | -$340.66 M(-3.2%) |
Mar 2018 | - | -$81.59 M(-26.7%) | -$352.03 M(-2.3%) |
Dec 2017 | -$360.37 M | -$111.27 M(+53.3%) | -$360.37 M(-2.4%) |
Sept 2017 | - | -$72.60 M(-16.1%) | -$369.14 M(-4.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2017 | - | -$86.56 M(-3.7%) | -$385.35 M(+2.5%) |
Mar 2017 | - | -$89.93 M(-25.1%) | -$376.08 M(-8.9%) |
Dec 2016 | -$412.83 M(+82.3%) | -$120.04 M(+35.2%) | -$412.83 M(+8.3%) |
Sept 2016 | - | -$88.81 M(+14.9%) | -$381.04 M(+11.1%) |
June 2016 | - | -$77.30 M(-39.0%) | -$343.12 M(+9.4%) |
Mar 2016 | - | -$126.67 M(+43.5%) | -$313.72 M(+38.5%) |
Dec 2015 | -$226.43 M(-20.1%) | -$88.25 M(+73.4%) | -$226.43 M(+30.9%) |
Sept 2015 | - | -$50.90 M(+6.3%) | -$173.00 M(+9.5%) |
June 2015 | - | -$47.89 M(+21.6%) | -$157.95 M(+106.2%) |
Mar 2015 | - | -$39.39 M(+13.1%) | -$76.58 M(-73.0%) |
Dec 2014 | -$283.23 M(+317.8%) | -$34.82 M(-2.8%) | -$283.23 M(+8.6%) |
Sept 2014 | - | -$35.84 M(-207.1%) | -$260.77 M(+1.6%) |
June 2014 | - | $33.47 M(-113.6%) | -$256.66 M(-15.5%) |
Mar 2014 | - | -$246.03 M(+1889.3%) | -$303.61 M(+347.9%) |
Dec 2013 | -$67.79 M(+55.3%) | -$12.37 M(-61.0%) | -$67.79 M(-21.3%) |
Sept 2013 | - | -$31.74 M(+135.5%) | -$86.11 M(+44.6%) |
June 2013 | - | -$13.48 M(+32.0%) | -$59.56 M(+16.4%) |
Mar 2013 | - | -$10.21 M(-66.7%) | -$51.17 M(+17.3%) |
Dec 2012 | -$43.64 M(+242.6%) | -$30.69 M(+491.7%) | -$43.64 M(+162.9%) |
Sept 2012 | - | -$5.19 M(+2.0%) | -$16.60 M(+16.5%) |
June 2012 | - | -$5.09 M(+89.8%) | -$14.25 M(+55.5%) |
Mar 2012 | - | -$2.68 M(-26.5%) | -$9.17 M(+41.3%) |
Dec 2011 | -$12.74 M(-15.6%) | -$3.65 M(+28.3%) | -$6.49 M(+128.3%) |
Sept 2011 | - | -$2.84 M | -$2.84 M |
Dec 2010 | -$15.09 M | - | - |
FAQ
- What is Intercept Pharmaceuticals annual net profit?
- What is the all time high annual net income for Intercept Pharmaceuticals?
- What is Intercept Pharmaceuticals annual net income year-on-year change?
- What is Intercept Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Intercept Pharmaceuticals?
- What is Intercept Pharmaceuticals quarterly net income year-on-year change?
- What is Intercept Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Intercept Pharmaceuticals?
- What is Intercept Pharmaceuticals TTM net income year-on-year change?
What is Intercept Pharmaceuticals annual net profit?
The current annual net income of ICPT is $221.82 M
What is the all time high annual net income for Intercept Pharmaceuticals?
Intercept Pharmaceuticals all-time high annual net profit is $221.82 M
What is Intercept Pharmaceuticals annual net income year-on-year change?
Over the past year, ICPT annual net profit has changed by +$313.24 M (+342.62%)
What is Intercept Pharmaceuticals quarterly net profit?
The current quarterly net income of ICPT is -$2.79 M
What is the all time high quarterly net income for Intercept Pharmaceuticals?
Intercept Pharmaceuticals all-time high quarterly net profit is $267.45 M
What is Intercept Pharmaceuticals quarterly net income year-on-year change?
Over the past year, ICPT quarterly net profit has changed by -$270.24 M (-101.04%)
What is Intercept Pharmaceuticals TTM net profit?
The current TTM net income of ICPT is -$61.61 M
What is the all time high TTM net income for Intercept Pharmaceuticals?
Intercept Pharmaceuticals all-time high TTM net profit is $221.82 M
What is Intercept Pharmaceuticals TTM net income year-on-year change?
Over the past year, ICPT TTM net profit has changed by -$267.97 M (-129.86%)